Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: A 12-week, multicenter, double-blind, randomized, parallel-group study
Authors:
- Michael H. DavidsonMDMichael H. Davidson
- Michael W. RooneyMRMichael W. Rooney
- Joan DruckerJDJoan Drucker
- H. Eugene GriffinHGH. Eugene Griffin
- Sonia OosmanSOSonia Oosman
- Michael BeckertMBMichael Beckert
- 1 December 2009
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 31 (12) , 2824-2838
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 studyAtherosclerosis, 2009
- Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination With Atorvastatin in Patients With Mixed DyslipidemiaThe American Journal of Cardiology, 2009
- Safety Considerations with Fibrate TherapyThe American Journal of Cardiology, 2007
- FenofibrateDrugs, 2007
- Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactionsExpert Opinion on Drug Safety, 2005
- Reducing Residual Risk for Patients on Statin Therapy: The Potential Role of Combination TherapyThe American Journal of Cardiology, 2005
- Additive Beneficial Effects of Fenofibrate Combined With Atorvastatin in the Treatment of Combined HyperlipidemiaJACC, 2005
- Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)The American Journal of Cardiology, 2005
- Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoproteinBiochemical Society Transactions, 2003
- Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemiaThe American Journal of Cardiology, 2000